266 related articles for article (PubMed ID: 34051709)
21. Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static
Ye Q; Wu J; Lu Y; Naganawa M; Gallezot JD; Ma T; Liu Y; Tanoue L; Detterbeck F; Blasberg J; Chen MK; Casey M; Carson RE; Liu C
Phys Med Biol; 2018 Sep; 63(17):175015. PubMed ID: 30095083
[TBL] [Abstract][Full Text] [Related]
22. The value of 18F-FDG PET/CT in the diagnosis of different size of solitary pulmonary nodules.
Tang K; Wang L; Lin J; Zheng X; Wu Y
Medicine (Baltimore); 2019 Mar; 98(11):e14813. PubMed ID: 30882661
[TBL] [Abstract][Full Text] [Related]
23. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
24. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
Khalaf M; Abdel-Nabi H; Baker J; Shao Y; Lamonica D; Gona J
J Hematol Oncol; 2008 Sep; 1():13. PubMed ID: 18808716
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.
Dewan NA; Gupta NC; Redepenning LS; Phalen JJ; Frick MP
Chest; 1993 Oct; 104(4):997-1002. PubMed ID: 8404239
[TBL] [Abstract][Full Text] [Related]
26. Peripheral pulmonary nodules: relationship between multi-slice spiral CT perfusion imaging and tumor angiogenesis and VEGF expression.
Ma SH; Le HB; Jia BH; Wang ZX; Xiao ZW; Cheng XL; Mei W; Wu M; Hu ZG; Li YG
BMC Cancer; 2008 Jun; 8():186. PubMed ID: 18590539
[TBL] [Abstract][Full Text] [Related]
27. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses.
Chen S; Li X; Chen M; Yin Y; Li N; Li Y
Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611
[TBL] [Abstract][Full Text] [Related]
28. Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients.
Schillaci O; Travascio L; Bolacchi F; Calabria F; Bruni C; Cicciò C; Guazzaroni M; Orlacchio A; Simonetti G
Radiol Med; 2009 Sep; 114(6):890-906. PubMed ID: 19579015
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
Tsushima Y; Tateishi U; Uno H; Takeuchi M; Terauchi T; Goya T; Kim EE
Ann Nucl Med; 2008 Aug; 22(7):571-7. PubMed ID: 18756359
[TBL] [Abstract][Full Text] [Related]
30. Artificial intelligence for detecting small FDG-positive lung nodules in digital PET/CT: impact of image reconstructions on diagnostic performance.
Schwyzer M; Martini K; Benz DC; Burger IA; Ferraro DA; Kudura K; Treyer V; von Schulthess GK; Kaufmann PA; Huellner MW; Messerli M
Eur Radiol; 2020 Apr; 30(4):2031-2040. PubMed ID: 31822970
[TBL] [Abstract][Full Text] [Related]
31. Is
Lee SH; Sung C; Lee HS; Yoon HY; Kim SJ; Oh JS; Song JW; Kim MY; Ryu JS
Ann Nucl Med; 2018 Aug; 32(7):492-498. PubMed ID: 29974372
[TBL] [Abstract][Full Text] [Related]
32. An 18F-FDG-PET/CT-based radiomics signature for estimating malignance probability of solitary pulmonary nodule.
Zheng J; Hao Y; Guo Y; Du M; Wang P; Xin J
Clin Respir J; 2024 May; 18(5):e13751. PubMed ID: 38725315
[TBL] [Abstract][Full Text] [Related]
33. The clinical value of texture analysis of dual-time-point
Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
[TBL] [Abstract][Full Text] [Related]
34. Predictive value of dual-time
Pahk K; Chung JH; Kim S; Lee SH
Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
[TBL] [Abstract][Full Text] [Related]
35. A model of malignant risk prediction for solitary pulmonary nodules on
Yu M; Wang Z; Yang G; Cheng Y
Thorac Cancer; 2020 May; 11(5):1211-1215. PubMed ID: 32162769
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the
McDermott S; Kilcoyne A; Wang Y; Scott JA; Halpern EF; Ackman JB
Clin Radiol; 2019 Mar; 74(3):187-195. PubMed ID: 30638605
[TBL] [Abstract][Full Text] [Related]
37. Dynamic contrast-enhanced MRI versus
Feng F; Qiang F; Shen A; Shi D; Fu A; Li H; Zhang M; Xia G; Cao P
Chin J Cancer Res; 2018 Feb; 30(1):21-30. PubMed ID: 29545716
[TBL] [Abstract][Full Text] [Related]
38. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the diagnostic efficacy of
Niyonkuru A; Chen X; Bakari KH; Wimalarathne DN; Bouhari A; Arnous MMR; Lan X
Cancer Med; 2020 Feb; 9(3):931-942. PubMed ID: 31837121
[TBL] [Abstract][Full Text] [Related]
40. Differential diagnosis of pulmonary lesions by parametric imaging in (18)F-FDG PET/CT dynamic multi-bed scanning.
Wang Q; Wang RF; Zhang J; Zhou Y
J BUON; 2013; 18(4):928-34. PubMed ID: 24344019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]